Cargando…

Implementing a tracking system for confirmatory diagnostic results after positive newborn screening for cystic fibrosis—implications for process quality and patient care

Newborn screening for cystic fibrosis (CF-NBS) was introduced in Germany in 2016. Currently, systematic follow-up of positive CF-NBS results is not implemented or reimbursed in the NBS program. We investigated results of confirmatory testing over 24 months after implementation of CF-NBS for a large...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gramer, Gwendolyn, Brockow, Inken, Labitzke, Christiane, Fang-Hoffmann, Junmin, Beivers, Andreas, Feyh, Patrik, Hoffmann, Georg F., Nennstiel, Uta, Sommerburg, Olaf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940155/ https://www.ncbi.nlm.nih.gov/pubmed/33104872 http://dx.doi.org/10.1007/s00431-020-03849-4

Ejemplares similares

The cost-effectiveness of tracking newborns with bilateral hearing impairment in Bavaria: a decision-analytic model
por: Langer, Astrid, et al.
Publicado: (2012)

Newborn Hearing Screening in Bavaria—Is It Possible to Reach the Quality Parameters?
por: Brockow, Inken, et al.
Publicado: (2018)

Is Our Newborn Screening Working Well? A Literature Review of Quality Requirements for Newborn Blood Spot Screening (NBS) Infrastructure and Procedures
por: Odenwald, Birgit, et al.
Publicado: (2023)

Maternal Vitamin B(12) Deficiency Detected by Newborn Screening—Evaluation of Causes and Characteristics
por: Reischl-Hajiabadi, Anna T., et al.
Publicado: (2022)

Combined Newborn Screening Allows Comprehensive Identification also of Attenuated Phenotypes for Methylmalonic Acidurias and Homocystinuria
por: Schnabel, Elena, et al.
Publicado: (2023)

Nutzen maximieren – Schaden minimieren: Neugeborenen-Screening in Deutschland
por: Brockow, Inken, et al.
Publicado: (2023)

TRACK-CF prospective cohort study: Understanding early cystic fibrosis lung disease
por: Steinke, Eva, et al.
Publicado: (2023)

Maternal vitamin deficiency mimicking multiple acyl-CoA dehydrogenase deficiency on newborn screening
por: Gramer, Gwendolyn, et al.
Publicado: (2021)

Efficacy and outcome of expanded newborn screening for metabolic diseases - Report of 10 years from South-West Germany *
por: Lindner, Martin, et al.
Publicado: (2011)

Machine Learning Methods Improve Specificity in Newborn Screening for Isovaleric Aciduria
por: Zaunseder, Elaine, et al.
Publicado: (2023)

Inquilinus limosus in Patients with Cystic Fibrosis, Germany
por: Wellinghausen, Nele, et al.
Publicado: (2005)

Pancreatitis-Associated Protein in Neonatal Screening for Cystic Fibrosis: Strengths and Weaknesses
por: Sommerburg, Olaf, et al.
Publicado: (2020)

Neugeborenen-Screening aus Trockenblut (NBS) in Deutschland: Status quo und Vorstellung eines Konzeptes zur Weiterentwicklung
por: Nennstiel, Uta, et al.
Publicado: (2023)

Sudden neonatal death in individuals with medium-chain acyl-coenzyme A dehydrogenase deficiency: limit of newborn screening
por: Mütze, Ulrike, et al.
Publicado: (2022)

Neugeborenen-Hörscreening in Deutschland – Ergebnisse der Evaluationen 2011/2012 und 2017/2018
por: Brockow, Inken, et al.
Publicado: (2023)

A high-throughput newborn screening approach for SCID, SMA, and SCD combining multiplex qPCR and tandem mass spectrometry
por: Tesorero, Rafael, et al.
Publicado: (2023)

Simultaneous determination of 3-hydroxypropionic acid, methylmalonic acid and methylcitric acid in dried blood spots: Second-tier LC-MS/MS assay for newborn screening of propionic acidemia, methylmalonic acidemias and combined remethylation disorders
por: Monostori, Péter, et al.
Publicado: (2017)

Incidence of maple syrup urine disease, propionic acidemia, and methylmalonic aciduria from newborn screening data
por: Chapman, Kimberly A., et al.
Publicado: (2018)

Prospective Newborn Screening for SCID in Germany: A First Analysis by the Pediatric Immunology Working Group (API)
por: Speckmann, Carsten, et al.
Publicado: (2023)

Optimization of the French cystic fibrosis newborn screening programme by a centralized tracking process
por: Munck, Anne, et al.
Publicado: (2017)

Effects of lumacaftor—ivacaftor therapy on cystic fibrosis transmembrane conductance regulator function in F508del homozygous patients with cystic fibrosis aged 2–11 years
por: Berges, Julian, et al.
Publicado: (2023)

Vergleich von Diagnosedaten nach der Einführung des Mukoviszidosescreenings bei Neugeborenen in Deutschland
por: Nährlich, Lutz, et al.
Publicado: (2023)

A Volatile and Dynamic Longitudinal Microbiome Is Associated With Less Reduction in Lung Function in Adolescents With Cystic Fibrosis
por: Metzger, Marisa I., et al.
Publicado: (2021)

Newborn Screening for Cystic Fibrosis in Delaware
por: Shenoy, Ambika, et al.
Publicado: (2018)

Supplementation with Red Palm Oil Increases β-Carotene and Vitamin A Blood Levels in Patients with Cystic Fibrosis
por: Sommerburg, Olaf, et al.
Publicado: (2015)

Primary carnitine deficiency – diagnosis after heart transplantation: better late than never!
por: Grünert, Sarah C., et al.
Publicado: (2020)

Cystic fibrosis diagnosed by state newborn screening: Or is it?
por: Fox, Maura, et al.
Publicado: (2020)

Changes in Microbiome Dominance Are Associated With Declining Lung Function and Fluctuating Inflammation in People With Cystic Fibrosis
por: Frey, Dario L., et al.
Publicado: (2022)

Communicating cystic fibrosis newborn screening results to parents
por: Seddon, L., et al.
Publicado: (2020)

Inconclusive Diagnosis after Newborn Screening for Cystic Fibrosis
por: Munck, Anne
Publicado: (2020)

History of Newborn Screening for Cystic Fibrosis—The Early Years
por: Travert, Georges, et al.
Publicado: (2020)

Diagnostic and Communication Challenges in Cystic Fibrosis Newborn Screening
por: DeCelie-Germana, Joan Kathleen, et al.
Publicado: (2023)

Increased Inflammatory Markers Detected in Nasal Lavage Correlate with Paranasal Sinus Abnormalities at MRI in Adolescent Patients with Cystic Fibrosis
por: Chung, Jaehi, et al.
Publicado: (2021)

Caring for a Child with Congenital Adrenal Hyperplasia Diagnosed by Newborn Screening: Parental Health-Related Quality of Life, Coping Patterns, and Needs
por: Rautmann, Laura, et al.
Publicado: (2023)

Molecular based newborn screening in Germany: Follow-up for cystinosis
por: Hohenfellner, Katharina, et al.
Publicado: (2019)

Antibiotic hypersensitivity in cystic fibrosis – Low frequency of anaphylaxis over 16 000 courses
por: Kowalik, Aleksandra, et al.
Publicado: (2022)

CFTR Modulator Therapy with Lumacaftor/Ivacaftor Alters Plasma Concentrations of Lipid-Soluble Vitamins A and E in Patients with Cystic Fibrosis
por: Sommerburg, Olaf, et al.
Publicado: (2021)

Why Do We Screen Newborn Infants for Cystic Fibrosis?
por: Barben, Jürg, et al.
Publicado: (2020)

Confirmatory Composite Analysis
por: Schuberth, Florian, et al.
Publicado: (2018)

The Role of Extended CFTR Gene Sequencing in Newborn Screening for Cystic Fibrosis
por: Bergougnoux, Anne, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_15j12pj2k7ie6h7sd27mjk52h4